🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/05/2007 | 48,76 | 49,75 | 48,76 | 49,62 | +1,80% | 2,04% | 10.144.326 |
| 10/05/2007 | 49,30 | 49,49 | 48,66 | 48,74 | -1,86% | 1,68% | 9.791.254 |
| 09/05/2007 | 49,80 | 49,95 | 49,42 | 49,67 | -0,36% | 1,07% | 9.351.199 |
| 08/05/2007 | 49,49 | 49,89 | 49,27 | 49,85 | +0,40% | 1,23% | 8.267.148 |
| 07/05/2007 | 49,48 | 49,68 | 49,43 | 49,65 | +0,21% | 0,50% | 6.984.396 |
| 04/05/2007 | 49,27 | 49,90 | 49,19 | 49,54 | +0,72% | 1,43% | 9.098.107 |
| 03/05/2007 | 49,05 | 49,43 | 48,74 | 49,19 | +0,62% | 1,40% | 8.609.739 |
| 02/05/2007 | 48,95 | 49,14 | 48,77 | 48,88 | +0,49% | 0,76% | 8.261.384 |
| 01/05/2007 | 49,28 | 49,36 | 48,23 | 48,65 | -0,89% | 2,30% | 11.230.682 |
| 30/04/2007 | 49,44 | 49,53 | 48,81 | 49,08 | -0,81% | 1,47% | 10.758.558 |
| 27/04/2007 | 49,87 | 49,96 | 49,18 | 49,48 | -1,09% | 1,57% | 11.739.591 |
| 26/04/2007 | 49,98 | 50,22 | 49,69 | 50,03 | +0,08% | 1,05% | 10.736.970 |
| 25/04/2007 | 49,32 | 50,10 | 49,01 | 49,99 | +1,53% | 2,21% | 12.653.657 |
| 24/04/2007 | 49,28 | 49,87 | 48,67 | 49,24 | -0,14% | 2,42% | 9.350.780 |
| 23/04/2007 | 48,96 | 49,71 | 48,66 | 49,30 | +0,35% | 2,14% | 15.446.158 |
| 20/04/2007 | 48,46 | 49,26 | 48,04 | 49,13 | +2,67% | 2,50% | 19.576.745 |
| 19/04/2007 | 47,48 | 48,08 | 47,23 | 47,85 | +0,93% | 1,79% | 17.947.838 |
| 18/04/2007 | 47,32 | 47,67 | 46,99 | 47,41 | -0,64% | 1,43% | 13.989.857 |
| 17/04/2007 | 48,00 | 48,14 | 47,54 | 47,72 | -0,62% | 1,25% | 12.249.758 |
| 16/04/2007 | 47,72 | 48,31 | 47,71 | 48,02 | +0,22% | 1,26% | 15.047.394 |
| 13/04/2007 | 47,13 | 48,47 | 46,99 | 47,91 | +8,30% | 3,14% | 48.973.774 |
| 12/04/2007 | 43,44 | 44,37 | 43,37 | 44,24 | +1,56% | 2,31% | 12.325.842 |
| 11/04/2007 | 43,70 | 43,78 | 43,26 | 43,56 | -0,46% | 1,18% | 8.498.127 |
| 10/04/2007 | 43,61 | 43,88 | 43,44 | 43,76 | +0,46% | 1,03% | 6.899.089 |
| 09/04/2007 | 43,38 | 43,57 | 43,17 | 43,56 | +0,24% | 0,92% | 6.363.351 |
| 05/04/2007 | 43,18 | 43,74 | 43,04 | 43,45 | +0,37% | 1,61% | 5.892.694 |
| 04/04/2007 | 43,16 | 43,33 | 42,98 | 43,29 | -0,02% | 0,82% | 6.175.235 |
| 03/04/2007 | 43,22 | 43,48 | 42,97 | 43,30 | +0,82% | 1,19% | 8.245.874 |
| 02/04/2007 | 42,55 | 43,22 | 42,48 | 42,95 | +1,90% | 1,73% | 14.062.274 |
| 30/03/2007 | 42,06 | 42,18 | 41,35 | 42,15 | +0,50% | 1,97% | 8.228.267 |